Reinsurance Group of America Inc

Reinsurance Group of America Inc(RZC)股票分析

$25.520

-0.031 (-0.12%)收盤時

Loading chart…
最高
25.690
開盤
25.410
成交量加權均價
25.53
成交量
23.90K
市值
—
最低
25.380
成交金額
610.12K
企業價值/稅息折舊攤銷前利潤(TTM)
—

Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The Company has four segments. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.

AI 分析 of Reinsurance Group of America Inc (RZC)

持有

Currently, RZC is not a strong buy due to its RSI of 67.319, indicating it is approaching overbought territory, and a 1-year change of -0.74%, which suggests it has underperformed over the past year. The stock is trading at $25.55, close to its 52-week high of $25.88, which limits upside potential.

RZC 常見問題 —— 由 Alphio AI 解答

Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The Company has four segments. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements. It operates in the Financials sector.

Currently, RZC is not a strong buy due to its RSI of 67.319, indicating it is approaching overbought territory, and a 1-year change of -0.74%, which suggests it has underperformed over the past year. The stock is trading at $25.55, close to its 52-week high of $25.88, which limits upside potential.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易